Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Nov 27:10:2788.
doi: 10.3389/fimmu.2019.02788. eCollection 2019.

Editorial: Cellular Therapies in Cancer

Hind Rafei  1 , Rohtesh S Mehta  2 , Katayoun Rezvani  2
Affiliations
Editorial

Editorial: Cellular Therapies in Cancer

Hind Rafei et al. Front Immunol. .
No abstract available

Keywords: T cells; adoptive cell therapy; cancer; cellular therapy; chimeric antigen receptor-T cell therapy; chimeric antigen receptor-natural killer cell therapy; immune effector cells; natural killer cells.

PubMed Disclaimer

Comment on

  • Editorial on the Research Topic Cellular Therapies in Cancer

References

    1. Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, et al. . Gene transfer into humans — Immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. New Engl J Med. (1990) 323:570–8. 10.1056/nejm199008303230904 - DOI - PubMed
    1. Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, Phan GQ, et al. . Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res. (2011) 17:4550–7. 10.1158/1078-0432.ccr-11-0116 - DOI - PMC - PubMed
    1. Mo Z, Du P, Wang G, Wang Y. The multi-purpose tool of tumor immunotherapy: gene-engineered T cells. J Cancer. (2017) 8:1690–703. 10.7150/jca.18681 - DOI - PMC - PubMed
    1. Nakagawa S, Matsuoka Y, Ichihara H, Yoshida H, Yoshida K, Ueoka R. New cancer immunotherapy using autologous lymphocytes activated with trastuzumab. Biol Pharm Bull. (2012) 35:1213–5. 10.1248/bpb.b12-00378 - DOI - PubMed

Publication types

LinkOut - more resources